Picard Medical rings NYSE Opening Bell on Dec 18, 2025, marking public company milestone

Picard Medical, Inc.

CEO Patrick NJ Schnegelsberg and management team to ring Opening Bell at NYSE on December 18, 2025.
Picard Medical, parent of SynCardia, highlights total artificial heart platform and FDA/Health Canada approvals.
Company touts more than 2,100 STAH implants across 27 countries and advancement of fully implantable Emperor system.
No financial results, guidance, or operational changes were disclosed in the press release.
Ceremonial event follows company's earlier listing on NYSE American under ticker PMI.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.